ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global SPECT and PET Radiopharmaceuticals Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33U15029
Home | Market Reports | Business & Industrial| Business Services
Global SPECT and PET Radiopharmaceuticals Market Research Report 2023
BUY CHAPTERS

Global SPECT and PET Radiopharmaceuticals Market Research Report 2025

Code: QYRE-Auto-33U15029
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cardinal Health
Curium Pharma
China Isotope & Radiation
Siemens AG
GE Healthcare
Jubilant Pharma
Novartis
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
Dongcheng

SPECT and PET Radiopharmaceuticals Market Size

The global market for SPECT and PET Radiopharmaceuticals was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 11020 million by 2031, growing at a CAGR of 7.5% during the forecast period.

SPECT and PET Radiopharmaceuticals Market

SPECT and PET Radiopharmaceuticals Market

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

Report Scope

This report aims to provide a comprehensive presentation of the global market for SPECT and PET Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SPECT and PET Radiopharmaceuticals.
The SPECT and PET Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global SPECT and PET Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SPECT and PET Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of SPECT and PET Radiopharmaceuticals Market Report

Report Metric Details
Report Name SPECT and PET Radiopharmaceuticals Market
Accounted market size in year US$ 6678 million
Forecasted market size in 2031 US$ 11020 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of SPECT and PET Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of SPECT and PET Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is SPECT and PET Radiopharmaceuticals Market growing?

Ans: The SPECT and PET Radiopharmaceuticals Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the SPECT and PET Radiopharmaceuticals Market size in 2031?

Ans: The SPECT and PET Radiopharmaceuticals Market size in 2031 will be US$ 11020 million.

What is the SPECT and PET Radiopharmaceuticals Market share by application?

Ans: Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis.

Who are the main players in the SPECT and PET Radiopharmaceuticals Market report?

Ans: The main players in the SPECT and PET Radiopharmaceuticals Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the SPECT and PET Radiopharmaceuticals Market report?

Ans: The Applications covered in the SPECT and PET Radiopharmaceuticals Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the SPECT and PET Radiopharmaceuticals Market report?

Ans: The Types covered in the SPECT and PET Radiopharmaceuticals Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

Recommended Reports

Radiopharmaceuticals Market

PET and SPECT Imaging

Nuclear Medicine Applications

1 SPECT and PET Radiopharmaceuticals Market Overview
1.1 Product Definition
1.2 SPECT and PET Radiopharmaceuticals by Type
1.2.1 Global SPECT and PET Radiopharmaceuticals Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 SPECT and PET Radiopharmaceuticals by Application
1.3.1 Global SPECT and PET Radiopharmaceuticals Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global SPECT and PET Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global SPECT and PET Radiopharmaceuticals Revenue 2020-2031
1.4.2 Global SPECT and PET Radiopharmaceuticals Sales 2020-2031
1.4.3 Global SPECT and PET Radiopharmaceuticals Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 SPECT and PET Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
2.2 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
2.3 Global SPECT and PET Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of SPECT and PET Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Date of Enter into This Industry
2.8 Global SPECT and PET Radiopharmaceuticals Market Competitive Situation and Trends
2.8.1 Global SPECT and PET Radiopharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest SPECT and PET Radiopharmaceuticals Players Market Share by Revenue
2.8.3 Global SPECT and PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global SPECT and PET Radiopharmaceuticals Market Scenario by Region
3.1 Global SPECT and PET Radiopharmaceuticals Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global SPECT and PET Radiopharmaceuticals Sales by Region: 2020-2031
3.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Region: 2020-2025
3.2.2 Global SPECT and PET Radiopharmaceuticals Sales by Region: 2026-2031
3.3 Global SPECT and PET Radiopharmaceuticals Revenue by Region: 2020-2031
3.3.1 Global SPECT and PET Radiopharmaceuticals Revenue by Region: 2020-2025
3.3.2 Global SPECT and PET Radiopharmaceuticals Revenue by Region: 2026-2031
3.4 North America SPECT and PET Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America SPECT and PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America SPECT and PET Radiopharmaceuticals Sales by Country (2020-2031)
3.4.3 North America SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe SPECT and PET Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe SPECT and PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe SPECT and PET Radiopharmaceuticals Sales by Country (2020-2031)
3.5.3 Europe SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific SPECT and PET Radiopharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific SPECT and PET Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Region (2020-2031)
3.6.3 Asia Pacific SPECT and PET Radiopharmaceuticals Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America SPECT and PET Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America SPECT and PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America SPECT and PET Radiopharmaceuticals Sales by Country (2020-2031)
3.7.3 Latin America SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa SPECT and PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2020-2031)
3.8.3 Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global SPECT and PET Radiopharmaceuticals Sales by Type (2020-2031)
4.1.1 Global SPECT and PET Radiopharmaceuticals Sales by Type (2020-2025)
4.1.2 Global SPECT and PET Radiopharmaceuticals Sales by Type (2026-2031)
4.1.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2020-2031)
4.2 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2020-2031)
4.2.1 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2020-2025)
4.2.2 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2026-2031)
4.2.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2020-2031)
4.3 Global SPECT and PET Radiopharmaceuticals Price by Type (2020-2031)
5 Segment by Application
5.1 Global SPECT and PET Radiopharmaceuticals Sales by Application (2020-2031)
5.1.1 Global SPECT and PET Radiopharmaceuticals Sales by Application (2020-2025)
5.1.2 Global SPECT and PET Radiopharmaceuticals Sales by Application (2026-2031)
5.1.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2020-2031)
5.2 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2020-2031)
5.2.1 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2020-2025)
5.2.2 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2026-2031)
5.2.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2020-2031)
5.3 Global SPECT and PET Radiopharmaceuticals Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Jubilant Pharma
6.3.1 Jubilant Pharma Company Information
6.3.2 Jubilant Pharma Description and Business Overview
6.3.3 Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
6.3.5 Jubilant Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis SPECT and PET Radiopharmaceuticals Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Curium Pharma
6.5.1 Curium Pharma Company Information
6.5.2 Curium Pharma Description and Business Overview
6.5.3 Curium Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
6.5.5 Curium Pharma Recent Developments/Updates
6.6 SIEMENS
6.6.1 SIEMENS Company Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio
6.6.5 SIEMENS Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Bracco Imaging
6.8.1 Bracco Imaging Company Information
6.8.2 Bracco Imaging Description and Business Overview
6.8.3 Bracco Imaging SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio
6.8.5 Bracco Imaging Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer SPECT and PET Radiopharmaceuticals Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Company Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Company Information
6.11.2 Aurobindo Pharma Description and Business Overview
6.11.3 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Mundipharma
6.12.1 Mundipharma Company Information
6.12.2 Mundipharma Description and Business Overview
6.12.3 Mundipharma SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio
6.12.5 Mundipharma Recent Developments/Updates
6.13 China Isotope & Radiation
6.13.1 China Isotope & Radiation Company Information
6.13.2 China Isotope & Radiation Description and Business Overview
6.13.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio
6.13.5 China Isotope & Radiation Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Company Information
6.14.2 Dongcheng Description and Business Overview
6.14.3 Dongcheng SPECT and PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 SPECT and PET Radiopharmaceuticals Industry Chain Analysis
7.2 SPECT and PET Radiopharmaceuticals Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 SPECT and PET Radiopharmaceuticals Production Mode & Process Analysis
7.4 SPECT and PET Radiopharmaceuticals Sales and Marketing
7.4.1 SPECT and PET Radiopharmaceuticals Sales Channels
7.4.2 SPECT and PET Radiopharmaceuticals Distributors
7.5 SPECT and PET Radiopharmaceuticals Customer Analysis
8 SPECT and PET Radiopharmaceuticals Market Dynamics
8.1 SPECT and PET Radiopharmaceuticals Industry Trends
8.2 SPECT and PET Radiopharmaceuticals Market Drivers
8.3 SPECT and PET Radiopharmaceuticals Market Challenges
8.4 SPECT and PET Radiopharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Cardinal Health
Curium Pharma
China Isotope & Radiation
Siemens AG
GE Healthcare
Jubilant Pharma
Novartis
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
Dongcheng
List of Tables
 Table 1. Global SPECT and PET Radiopharmaceuticals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global SPECT and PET Radiopharmaceuticals Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global SPECT and PET Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2024
 Table 4. Global SPECT and PET Radiopharmaceuticals Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global SPECT and PET Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market SPECT and PET Radiopharmaceuticals Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of SPECT and PET Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Product Type & Application
 Table 12. Global Key Manufacturers of SPECT and PET Radiopharmaceuticals, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global SPECT and PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT and PET Radiopharmaceuticals as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global SPECT and PET Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global SPECT and PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
 Table 18. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2020-2025)
 Table 19. Global SPECT and PET Radiopharmaceuticals Sales by Region (2026-2031) & (K Dose)
 Table 20. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2026-2031)
 Table 21. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
 Table 23. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2026-2031)
 Table 25. North America SPECT and PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America SPECT and PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 27. North America SPECT and PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 28. North America SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America SPECT and PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe SPECT and PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe SPECT and PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific SPECT and PET Radiopharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific SPECT and PET Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific SPECT and PET Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America SPECT and PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America SPECT and PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America SPECT and PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America SPECT and PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global SPECT and PET Radiopharmaceuticals Sales (K Dose) by Type (2020-2025)
 Table 51. Global SPECT and PET Radiopharmaceuticals Sales (K Dose) by Type (2026-2031)
 Table 52. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
 Table 53. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2026-2031)
 Table 54. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 57. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 58. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Type (2020-2025)
 Table 59. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Type (2026-2031)
 Table 60. Global SPECT and PET Radiopharmaceuticals Sales (K Dose) by Application (2020-2025)
 Table 61. Global SPECT and PET Radiopharmaceuticals Sales (K Dose) by Application (2026-2031)
 Table 62. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
 Table 63. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2026-2031)
 Table 64. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global SPECT and PET Radiopharmaceuticals Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 67. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 68. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Application (2020-2025)
 Table 69. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Application (2026-2031)
 Table 70. Cardinal Health Company Information
 Table 71. Cardinal Health Description and Business Overview
 Table 72. Cardinal Health SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Cardinal Health SPECT and PET Radiopharmaceuticals Product
 Table 74. Cardinal Health Recent Developments/Updates
 Table 75. GE Healthcare Company Information
 Table 76. GE Healthcare Description and Business Overview
 Table 77. GE Healthcare SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. GE Healthcare SPECT and PET Radiopharmaceuticals Product
 Table 79. GE Healthcare Recent Developments/Updates
 Table 80. Jubilant Pharma Company Information
 Table 81. Jubilant Pharma Description and Business Overview
 Table 82. Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Jubilant Pharma SPECT and PET Radiopharmaceuticals Product
 Table 84. Jubilant Pharma Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Novartis SPECT and PET Radiopharmaceuticals Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Curium Pharma Company Information
 Table 91. Curium Pharma Description and Business Overview
 Table 92. Curium Pharma SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Curium Pharma SPECT and PET Radiopharmaceuticals Product
 Table 94. Curium Pharma Recent Developments/Updates
 Table 95. SIEMENS Company Information
 Table 96. SIEMENS Description and Business Overview
 Table 97. SIEMENS SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. SIEMENS SPECT and PET Radiopharmaceuticals Product
 Table 99. SIEMENS Recent Developments/Updates
 Table 100. Lantheus Company Information
 Table 101. Lantheus Description and Business Overview
 Table 102. Lantheus SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Lantheus SPECT and PET Radiopharmaceuticals Product
 Table 104. Lantheus Recent Developments/Updates
 Table 105. Bracco Imaging Company Information
 Table 106. Bracco Imaging Description and Business Overview
 Table 107. Bracco Imaging SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Bracco Imaging SPECT and PET Radiopharmaceuticals Product
 Table 109. Bracco Imaging Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Bayer SPECT and PET Radiopharmaceuticals Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Eli Lilly Company Information
 Table 116. Eli Lilly Description and Business Overview
 Table 117. Eli Lilly SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Eli Lilly SPECT and PET Radiopharmaceuticals Product
 Table 119. Eli Lilly Recent Developments/Updates
 Table 120. Aurobindo Pharma Company Information
 Table 121. Aurobindo Pharma Description and Business Overview
 Table 122. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product
 Table 124. Aurobindo Pharma Recent Developments/Updates
 Table 125. Mundipharma Company Information
 Table 126. Mundipharma Description and Business Overview
 Table 127. Mundipharma SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Mundipharma SPECT and PET Radiopharmaceuticals Product
 Table 129. Mundipharma Recent Developments/Updates
 Table 130. China Isotope & Radiation Company Information
 Table 131. China Isotope & Radiation Description and Business Overview
 Table 132. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product
 Table 134. China Isotope & Radiation Recent Developments/Updates
 Table 135. Dongcheng Company Information
 Table 136. Dongcheng Description and Business Overview
 Table 137. Dongcheng SPECT and PET Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Dongcheng SPECT and PET Radiopharmaceuticals Product
 Table 139. Dongcheng Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. SPECT and PET Radiopharmaceuticals Distributors List
 Table 143. SPECT and PET Radiopharmaceuticals Customers List
 Table 144. SPECT and PET Radiopharmaceuticals Market Trends
 Table 145. SPECT and PET Radiopharmaceuticals Market Drivers
 Table 146. SPECT and PET Radiopharmaceuticals Market Challenges
 Table 147. SPECT and PET Radiopharmaceuticals Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of SPECT and PET Radiopharmaceuticals
 Figure 2. Global SPECT and PET Radiopharmaceuticals Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global SPECT and PET Radiopharmaceuticals Market Share by Type: 2024 & 2031
 Figure 4. Diagnostic Radiopharmaceuticals Product Picture
 Figure 5. Therapeutic Radiopharmaceuticals Product Picture
 Figure 6. Global SPECT and PET Radiopharmaceuticals Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global SPECT and PET Radiopharmaceuticals Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global SPECT and PET Radiopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global SPECT and PET Radiopharmaceuticals Market Size (2020-2031) & (US$ Million)
 Figure 13. Global SPECT and PET Radiopharmaceuticals Sales (2020-2031) & (K Dose)
 Figure 14. Global SPECT and PET Radiopharmaceuticals Average Price (US$/Dose) & (2020-2031)
 Figure 15. SPECT and PET Radiopharmaceuticals Report Years Considered
 Figure 16. SPECT and PET Radiopharmaceuticals Sales Share by Manufacturers in 2024
 Figure 17. Global SPECT and PET Radiopharmaceuticals Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest SPECT and PET Radiopharmaceuticals Players: Market Share by Revenue in SPECT and PET Radiopharmaceuticals in 2024
 Figure 19. SPECT and PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global SPECT and PET Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 22. North America SPECT and PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 23. United States SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 26. Europe SPECT and PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 27. Germany SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2020-2031)
 Figure 34. China SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 42. Latin America SPECT and PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE SPECT and PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of SPECT and PET Radiopharmaceuticals by Type (2020-2031)
 Figure 52. Global Revenue Market Share of SPECT and PET Radiopharmaceuticals by Type (2020-2031)
 Figure 53. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Type (2020-2031)
 Figure 54. Global Sales Market Share of SPECT and PET Radiopharmaceuticals by Application (2020-2031)
 Figure 55. Global Revenue Market Share of SPECT and PET Radiopharmaceuticals by Application (2020-2031)
 Figure 56. Global SPECT and PET Radiopharmaceuticals Price (US$/Dose) by Application (2020-2031)
 Figure 57. SPECT and PET Radiopharmaceuticals Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Global Radiopharmaceutical Market Research Report 2025
Global Nuclear Medicine Market Research Report 2025
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Radiopharmaceutical Therapy Market Research Report 2025
Global SPECT Radiopharmaceuticals Market Research Report 2025
Global Radiopharmaceuticals for Diagnosis Market Research Report 2024
Global Diagnostic Radiopharmaceuticals Market Research Report 2024
Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024
Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Targeted Radiopharmaceuticals Market Research Report 2024
Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radiopharmaceutical Injector Market Research Report 2025
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Therapeutic Radioisotopes Market Insights Forecast to 2030
Global Radioisotopes in Medicine Market Research Report 2025
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030

RELATED REPORTS

Global Embedding Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9Q19947
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global 3D Printed Opthalmic Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4Q7858
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Item Level RFID Tag Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22J19673
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Knee Slider Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13F19923
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions